Researchers compared the safety and efficacy of injectable cabotegravir vs oral tenofovir diphosphate plus emtricitabine for the prevention of HIV infection among women.
Mental health struggles may play a larger role in approaching HIV prevention than patients realize. How do symptoms of depression and anxiety affect HIV risk behaviors, and how can health care professionals educate patients and increase prevention?
Researchers conducted a study to determine whether the risk for extended-spectrum -lactamase-producing enterobacterales is associated with number of sexual partners and increased sexual activity.
Researchers conducted a study to assess the pharmacokinetics and effect of dolutegravir-based antiretroviral therapy in combination with dihydroartemisinin/piperaquine in women with HIV infection who were pregnant.
In this meta-analysis, researchers evaluated the risk for kidney function impairment in patients receiving tenofovir disoproxil fumarate-based pre-exposure prophylaxis against HIV infection.
Researchers conducted a study that evaluated the efficacy and cost-effectiveness of long-acting injectable cabotegravir compared with oral tenofovir-based treatment for use in HIV pre-exposure prophylaxis programs.
Investigators assessed the safety and pharmacokinetics of monoclonal antibodies VRC07-523LS and PGT121 administered subcutaneously for protection against HIV infection.
Researchers assessed the effectiveness of the Six Moments of Harm Reduction, an educational tool for clinicians designed to improve knowledge on harm reduction and injection-associated infections.
Researchers conducted a study to assess the effect of the COVID-19 pandemic on HIV pre-exposure prophylaxis (PrEP) prescriptions and new PrEP users in the US.
In this longitudinal study, investigators assessed the prevalence of HIV-1 transmitted drug resistance in Rhode Island between 2004 and 2020.
